Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Cirrhosis-related Refractory Ascites
NCT05430243Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in ascites, sponsored by Alexandria University. Started Apr 2022; status: completed.
02
Drugs
empagliflozin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT05430243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05430243.